Hedge Fund - Samsara BioCapital
Acelyrin Inc ()
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $6,231,864 | 1.11% | 2,523,022 | $ |
| 2 | 2024 - Q4 (2024-12-31) | $7,922,289 | 1.08% | 2,523,022 | $ |
| 3 | 2024 - Q3 (2024-09-30) | $12,438,498 | 2.39% | 2,523,022 | $ |
| 4 | 2024 - Q2 (2024-06-30) | $11,126,527 | 2.32% | 2,523,022 | $ |
| 5 | 2024 - Q1 (2024-03-31) | $17,030,399 | 2.63% | 2,523,022 | $ |
| 6 | 2023 - Q4 (2023-12-31) | $18,821,744 | 2.92% | 2,523,022 | $ |
| 7 | 2023 - Q3 (2023-09-30) | $24,220,658 | 7.41% | 2,381,579 | $ |
| 8 | 2023 - Q2 (2023-06-30) | $47,150,860 | 8.27% | 2,256,022 | $ |
The displayed share prices are average quarterly stock market prices.